DiaSorin S.p.A.
- BID
67.68
- ASK
67.7
- 558 Units262 Units
- 07/21, 16:37:59 PM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
21.43%
Market Cap
3.70 Bil.
P/E Ratio
24.83
Dividend Yield
1.89 %
Earnings per Share
2.76 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 67.84 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 04:31:58 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 70.34 | 67.58 |
| PREV. DAY'S PRICE | 69.8 | (07/20) |
| CHANGE DAY BEFORE | -1.96 | -2.81 % |
| 52 WEEK HIGH / LOW | 90.56 (07/25) | 53.54 (03/23) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 2.87 | 3.37 | 2.76 | 3.91 | 4.37 |
DIVIDENDS PER SHARE | 1.15 | 1.20 | 1.30 | 1.30 | 1.38 |
DIVIDEND YIELD IN % | 1.23 % | 1.21 % | 1.89 % | - | - |
DIVIDEND GROWTH IN % | 4.55 % | 4.35 % | 8.33 % | - | - |
PRICE - EARNINGS RATIO | 32.52 | 29.57 | 24.83 | 17.73 | 15.86 |
PRICE - BOOK RATIO | 3.23 | 2.98 | 2.30 | - | - |
PRICE - SALES RATIO | 4.53 | 4.72 | 3.23 | - | - |
PRICE - CASH FLOW RATIO | 16.68 | 15.58 | 11.27 | - | - |
Master Data
| WKN | A0MTB2 |
| ISIN | IT0003492391 |
| SYMBOL | 34D |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | DiaSorin |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 53.00 Mil. |
| MARKET CAPITALISATION | 3.70 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.64 % | 8.37 % | 9.99 % | -7.15 % | -21.43 % | -23.54 % | -57.36 % | 1.26 % |
| HIGH | 70.40 | 70.92 | 72.80 | 76.24 | 90.56 | 109.90 | 207.10 | 77.36 |
| LOW | 68.04 | 63.14 | 56.26 | 53.54 | 53.54 | 53.54 | 53.54 | 53.54 |
Dividende
pro Aktie
Company profile
DiaSorin SpA engages in developing, producing and marketing reagent kits for laboratory diagnostics. It operates through following segments Immunodiagnostics, Molecular Diagnostics, and Life Science. The Immunodiagnostics segment engages in the development of new tests based on complex algorithms. The Molecular Diagnostics segment focuses on providing specialty tests and complex multiplex solutions. The Life Science segment offers diagnostic instruments and technology. The firm provides clinical services in areas like Infectious diseases, bone and mineral, endocrinology, hypertension, oncology, stool diagnostics and autoimmunity. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Structured products for DiaSorin S.p.A.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.